Home › Free Stock Grades › XENE
Xenon Pharmaceuticals Inc. (XENE) Stock Grade
XENE · Healthcare
B
Market Cap
$3.6B
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
-4612.1%
Return on Equity
—
Dividend Yield
None
About Xenon Pharmaceuticals Inc.'s fundamentals
Xenon Pharmaceuticals is a $3.6 billion market cap biotechnology company with no dividend yield. The company reported zero revenue growth year-over-year and a significant net loss, resulting in a negative net margin of -4612.1%, indicating substantial operating expenses relative to minimal or break-even revenue. Traditional valuation metrics like P/E ratio and return on equity are not applicable given the company's loss position.